Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Alibaba

JPMorgan Chase & Co

Lockheed Martin

Undervalued stocks that have strong fundamentals and pay healthy dividends. Low beta stocks as market valuations look stretched.

4 Undervalued Stocks to Add to Your Large-Cap Portfolio

Lumen Technologies

ONEOK

You won't find better yields in the S&P 500.

Need Income? These 3 High-Yield Dividend Stocks Are Leading the Market

Altria increased earnings in 2020. Mo' Money! Altria increased its dividend in 2020. Mo' Money!

'MO' Money, More Money: Altria

Altria Group has been named as a Top 25 ''Dividend Giant'' by ETF Channel, with a whopping $9.14B worth of stock held by ETF

Altria Group A Top 25 Dividend Giant With 7.85% Yield

The market has been very strong, and if you are concerned about potential volatility, the 7.9% dividend yield on this blue chip stock is steady, solid and growing. Altria's dividend has been increased over 50 years in a row, and the share repurchase program is nice too.

Altria's Recession-Proof 7.9% Dividend Yield Worth Considering

Altria's CAGNY presentation was based on its plan to move beyond smoking. From 2015 to 2020, tobacco volumes only fell 1% per year when you include non-combustibles. Altria tries to be ESG, but ESG funds aren't investing in it.

Altria Is Moving Beyond Smoking

EMCOR Group

Gray TV

Hartford Financial Services Group

Disappointing jobless claims and weak data from Walmart, among other factors, sent all the major indices down. But Q.ai's deep learning algorithms have assessed the markets to bring you today's top buys.

Top Stocks To Buy Today As Jobless Claims Send Markets Down

Altria (MO) gains from rising popularity of IQOS and oral tobacco offerings. Moreover, pricing power is supporting revenue growth.

Altria (MO) Poised on Solid Pricing, Growth in Low Risk Products

RICHMOND, Va.--(BUSINESS WIRE)---- $MO--Altria Presents as Part of the Consumer Analyst Group of New York Conference; Reaffirms 2021 Full-Year Earnings Guidance

Altria Presents as Part of the Consumer Analyst Group of New York Conference; Reaffirms 2021 Full-Year Earnings Guidance

RICHMOND, Va.--(BUSINESS WIRE)---- $MO--Altria Announces Pricing of Previously Announced Cash Tender Offers

Altria Announces Pricing of Previously Announced Cash Tender Offers

Bank of America

Charter Communications

Alphabet

Unilever

Charter, Swedish Match, and Altria remain the top 3 stocks in our coverage, each offering a near-20% forecasted annualized return.

Librarian Capital's Monthly Top Buys And Price Moves - January 2021

RICHMOND, Va.--(BUSINESS WIRE)---- $MO--Altria Announces Early Results and Upsize of Previously Announced Cash Tender Offers for Certain Outstanding Notes

Altria Announces Early Results and Upsize of Previously Announced Cash Tender Offers for Certain Outstanding Notes

Altria identifies as a company with a competitive advantage as in 2020 its gross profit margin exceeded 60% and their net income conversion rate exceeded 20%.

Altria: The Ultimate Vice Stock Is Yielding 8% And I Added It To My Dividend Portfolio

Apple

Sykes Enterprises

Verizon

Verizon Communications Inc 5.9 % Notes 2014-15.2.54 Sr

The February rally couldn't sustain its pace forever. It's only natural for markets to drop, but investors are keeping positive.

Top Stocks To Buy Today As Markets Drop But Outlook Remains Positive

RICHMOND, Va.--(BUSINESS WIRE)---- $MO--Altria Group Joins The Valuable 500 in Support of Individuals with Disabilities

Altria Group Joins The Valuable 500 in Support of Individuals with Disabilities

Bristol-Myers

Comcast

AT&T

Valero Energy

Market veterans have seen this movie before: unfounded market optimism that lacks a real foundation of fundamental valuation but instead rests on psychological factors.

BofA Securities Warns of 5% to 10% Sell-Off: 5 Safe Dividend Stocks to Buy Now

Aurora Cannabis

Aphria

Canopy Growth

Cronos Group

Curaleaf Holdings, Inc.

GW Pharmaceuticals

Jazz Pharmaceuticals

SNDL Inc.

Constellation Brands

Tilray Brands

The sector is hot again on the heels of two large deals.

Will There Be More M&A for the Cannabis Industry in 2021?

Duke Energy

Annaly Capital

With yields ranging from 4.1% to 10.5%, these high-quality companies won't cause income investors to lose sleep.

4 High-Yield Dividend Stocks You Can Safely Buy If the Market Crashes

The company's 8% dividend yield looks like it is here to stay.

Altria Shows Again Why It Is the Ultimate Income Stock

Philip Morris

Turning Point Brands

RRPs, Pricing Light Up Tobacco Space Prospects: 3 Stock to Watch

RICHMOND, Va.--(BUSINESS WIRE)---- $MO--ALTRIA ANNOUNCES CASH TENDER OFFERS FOR CERTAIN OUTSTANDING NOTES

Altria Announces Cash Tender Offers for Certain Outstanding Notes

Altria expects 3% to 6% EPS growth in 2021. on! continued to expand distribution. Marlboro had a good quarter in terms of market share. Black & Mild had strong sales growth.

Altria Is An Innovation-Driven Company

Altria released Q4 2020 results on Thursday, with U.S. cigarette volume trends again stable, partly thanks to more stay-at-home during COVID. Smokeables revenues were up 9.1% year-on-year in Q4 (helped by inventory) and up 6.5% for the full-year; 2020 EPS was up 3.6%.

Altria: Steady Progress In Q4, 8% Dividend Yield And Now Buybacks

Altria is trying to become less of a cigarette company as demand fades. Is the stock a buy after breaking out then giving back its gains?

MO Stock: Is Marlboro Maker Altria A Buy After Q4 Earnings?

Biogen

British American Tobacco

GlaxoSmithKline

Imperial Brands PLC

Merck

Roche Holding AG

Sanofi

Our three-step process focuses on wide-moat stocks (as per Morningstar's rating).

News for Altria Stock (MO)